查看購物車
  • English
封面
市場調查報告書
商品編碼
1905133

日本抗生素市場報告（按作用機制、藥物類別、抗菌譜、給藥途徑、最終用戶和地區分類，2026-2034年）

Japan Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本抗生素市場規模達33.758億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到60.744億美元，2026年至2034年期間的複合年成長率（CAGR）為6.75%。傳染病日益流行，導致手術、醫療程序和住院治療增多，從而增加了對抗生素的需求，這是推動市場成長的主要因素。

本報告解答的關鍵問題：

  • 日本抗生素市場目前的表現如何？未來幾年又將如何發展？
  • 新冠疫情對日本抗生素市場產生了哪些影響？
  • 日本抗生素市場依作用機制分類的組成是怎樣的？
  • 日本抗生素市場依藥物類別分類的組成是怎樣的？
  • 日本抗生素市場依抗菌譜分類的組成是怎樣的？
  • 日本抗生素市場依給藥途徑分類的組成是怎樣的？
  • 日本抗生素市場以最終用戶分類的組成是怎樣的？
  • 日本抗生素市場價值鏈的各個階段有哪些？
  • 日本抗生素產業的主要促進因素和挑戰是什麼？
  • 日本抗生素市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本抗生素市場的競爭程度如何？

目錄

第1章：序言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 數據來源
  • 市場估算
  • 預測方法

第3章：執行概要

第4章：日本抗生素市場－簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章：日本抗生素市場概況

  • 歷史及當前市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本抗生素市場－依作用機制分類

  • 細胞壁合成抑制劑
  • 蛋白質合成抑制劑
  • DNA合成抑制劑
  • RNA合成抑制劑
  • 分枝菌酸抑制劑
  • 其他

第7章：日本抗生素市場－依藥物類別分類

  • 頭孢菌素
  • 青黴素
  • 氟喹諾酮
  • 大環內酯類
  • 碳青黴烯類
  • 氨基糖苷類
  • 其他

第8章：日本抗生素市場－依抗菌譜分類

  • 廣效抗生素
  • 窄譜抗生素

第9章：日本抗生素市場－依給藥途徑分類

  • 口服
  • 腸外
  • 主題
  • 其他

第10章：日本抗生素市場－以最終用戶分類

  • 醫院
  • 專科診所
  • 其他

第11章：日本抗生素市場－按地區分類

  • 關東地區
  • 關西/近畿地區
  • 中部/中部地區
  • 九州·沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第12章：日本抗生素市場－競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭格局分析
  • 公司評估象限

第13章：關鍵參與者簡介

第14章：日本抗生素市場－產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第15章：附錄

簡介目錄
Product Code: SR112026A18083

Japan antibiotics market size reached USD 3,375.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 6,074.4 Million by 2034, exhibiting a growth rate (CAGR) of 6.75% during 2026-2034. The escalating prevalence of infectious diseases, which also leads to surgeries, medical procedures, and hospitalizations, thereby increasing the need for antibiotics to prevent and treat such conditions, is primarily driving the market.

Antibiotics are powerful medications used to treat bacterial infections. They work by targeting and killing bacteria or inhibiting their growth. Antibiotics can be categorized into several classes, each with its unique mechanism of action. They are prescribed by healthcare professionals after diagnosing a bacterial infection. It's crucial to use antibiotics as directed and complete the prescribed course to ensure the complete eradication of bacteria. Failure to do so can lead to antibiotic resistance, where bacteria become less responsive to these drugs. While antibiotics are effective against bacteria, they do not work on viral infections like the common cold or flu. Overuse or misuse of antibiotics has raised concerns about the development of antibiotic-resistant strains of bacteria, making it essential to use them judiciously and only when necessary. Research into new antibiotics and alternative treatments continues to be a critical area of focus in healthcare to combat evolving bacterial threats.

Japan Antibiotics Market Trends:

The antibiotics market in Japan has witnessed significant growth over the years, and several key drivers have propelled this upward trajectory. Firstly, the rise in bacterial infections has necessitated an increased demand for antibiotics. Additionally, the expansion of the geriatric population, which is more susceptible to infections, has further fueled this need. Moreover, advancements in biotechnological methods have led to the discovery of novel antibiotics, thus expanding the market. Furthermore, the spread of antibiotic-resistant pathogens has created an urgency to invest in R&D, leading to more innovations and developments in the sector. Notably, the increasing support and funding from both government and private entities have been pivotal in pushing forward research initiatives. Another crucial factor is the growing awareness among people about bacterial infections and their implications, coupled with easy access to healthcare facilities. Consequently, there is a steady growth in antibiotic prescriptions, boosting the market. On the other hand, though the need for effective treatment regimens is undeniable, there are concerns about antibiotic overuse, potentially causing resistance. Nevertheless, the overall need for effective antibacterial treatments remains paramount, and these market drivers play a crucial role in shaping the industry's landscape.

Japan Antibiotics Market Segmentation:

Action Mechanism Insights:

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

Drug Class Insights:

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolide
  • Carbapenem
  • Aminoglycoside
  • Others

Spectrum of Activity Insights:

  • Broad-Spectrum Antibiotics
  • Narrow-Spectrum Antibiotics

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan antibiotics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan antibiotics market?
  • What is the breakup of the Japan antibiotics market on the basis of action mechanism?
  • What is the breakup of the Japan antibiotics market on the basis of drug class?
  • What is the breakup of the Japan antibiotics market on the basis of spectrum of activity?
  • What is the breakup of the Japan antibiotics market on the basis of route of administration?
  • What is the breakup of the Japan antibiotics market on the basis of end user?
  • What are the various stages in the value chain of the Japan antibiotics market?
  • What are the key driving factors and challenges in the Japan antibiotics?
  • What is the structure of the Japan antibiotics market and who are the key players?
  • What is the degree of competition in the Japan antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Antibiotics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Antibiotics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Antibiotics Market - Breakup by Action Mechanism

  • 6.1 Cell Wall Synthesis Inhibitors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Protein Synthesis Inhibitors
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 DNA Synthesis Inhibitors
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 RNA Synthesis Inhibitors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Mycolic Acid Inhibitors
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Others
    • 6.6.1 Historical and Current Market Trends (2020-2025)
    • 6.6.2 Market Forecast (2026-2034)

7 Japan Antibiotics Market - Breakup by Drug Class

  • 7.1 Cephalosporin
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Penicillin
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Fluoroquinolone
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Macrolide
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Aminoglycoside
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2020-2025)
    • 7.6.3 Market Forecast (2026-2034)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2020-2025)
    • 7.7.2 Market Forecast (2026-2034)

8 Japan Antibiotics Market - Breakup by Spectrum of Activity

  • 8.1 Broad-Spectrum Antibiotics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Narrow-Spectrum Antibiotics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Antibiotics Market - Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Topical
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2020-2025)
    • 9.4.2 Market Forecast (2026-2034)

10 Japan Antibiotics Market - Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Others
    • 10.3.1 Historical and Current Market Trends (2020-2025)
    • 10.3.2 Market Forecast (2026-2034)

11 Japan Antibiotics Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Action Mechanism
    • 11.1.4 Market Breakup by Drug Class
    • 11.1.5 Market Breakup by Spectrum of Activity
    • 11.1.6 Market Breakup by Route of Administration
    • 11.1.7 Market Breakup by End User
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Action Mechanism
    • 11.2.4 Market Breakup by Drug Class
    • 11.2.5 Market Breakup by Spectrum of Activity
    • 11.2.6 Market Breakup by Route of Administration
    • 11.2.7 Market Breakup by End User
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Action Mechanism
    • 11.3.4 Market Breakup by Drug Class
    • 11.3.5 Market Breakup by Spectrum of Activity
    • 11.3.6 Market Breakup by Route of Administration
    • 11.3.7 Market Breakup by End User
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Action Mechanism
    • 11.4.4 Market Breakup by Drug Class
    • 11.4.5 Market Breakup by Spectrum of Activity
    • 11.4.6 Market Breakup by Route of Administration
    • 11.4.7 Market Breakup by End User
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Action Mechanism
    • 11.5.4 Market Breakup by Drug Class
    • 11.5.5 Market Breakup by Spectrum of Activity
    • 11.5.6 Market Breakup by Route of Administration
    • 11.5.7 Market Breakup by End User
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Action Mechanism
    • 11.6.4 Market Breakup by Drug Class
    • 11.6.5 Market Breakup by Spectrum of Activity
    • 11.6.6 Market Breakup by Route of Administration
    • 11.6.7 Market Breakup by End User
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Action Mechanism
    • 11.7.4 Market Breakup by Drug Class
    • 11.7.5 Market Breakup by Spectrum of Activity
    • 11.7.6 Market Breakup by Route of Administration
    • 11.7.7 Market Breakup by End User
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Action Mechanism
    • 11.8.4 Market Breakup by Drug Class
    • 11.8.5 Market Breakup by Spectrum of Activity
    • 11.8.6 Market Breakup by Route of Administration
    • 11.8.7 Market Breakup by End User
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Antibiotics Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Product Portfolio
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Product Portfolio
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Product Portfolio
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Product Portfolio
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Product Portfolio
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Antibiotics Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix